Scientists call for randomized deprescribing trials to address anticholinergic drug use as a potentially modifiable and reversible risk factor for dementia, a growing public health issue.
from Latest Science News -- ScienceDaily http://bit.ly/2LeFV8r
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment